Compass therapeutics to participate in the wedbush pacgrow healthcare conference

Boston, aug. 07, 2024 (globe newswire) -- compass therapeutics, inc. (nasdaq: cmpx), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the company will present at the wedbush pacgrow healthcare conference taking place in new york city, new york on tuesday, august 13, 2024, at 11 am et.
CMPX Ratings Summary
CMPX Quant Ranking